Hims & Hers Health Cash Flow from Operating Activities 2020-2025 | HIMS

Hims & Hers Health cash flow from operating activities for the twelve months ending June 30, 2025 was $0.615B, a 167.03% increase year-over-year.

  • Hims & Hers Health annual cash flow from operating activities for 2024 was $0.251B, a 241.69% increase from 2023.
  • Hims & Hers Health annual cash flow from operating activities for 2023 was $0.073B, a 376.97% decline from 2022.
  • Hims & Hers Health annual cash flow from operating activities for 2022 was $-0.027B, a 22.9% decline from 2021.

Hims & Hers Health Cash Flow from Operating Activities 2020-2025 | HIMS

  • Hims & Hers Health annual cash flow from operating activities for 2024 was $0.251B, a 241.69% increase from 2023.
  • Hims & Hers Health annual cash flow from operating activities for 2023 was $0.073B, a 376.97% decline from 2022.
  • Hims & Hers Health annual cash flow from operating activities for 2022 was $-0.027B, a 22.9% decline from 2021.
Related Stocks
Company NameMarket
Cap
Veeva Systems (VEEV)$44B
Tempus AI (TEM)$13.2B
Doximity (DOCS)$12.7B
IRhythm Technologies (IRTC)$5.5B
Hinge Health (HNGE)$4.4B
Privia Health (PRVA)$2.8B
Inspire Medical Systems (INSP)$2.8B
Heartflow (HTFL)$2.6B
Phreesia (PHR)$1.9B
Enovis (ENOV)$1.8B
10x Genomics (TXG)$1.7B
Omnicell (OMCL)$1.5B
Schrodinger (SDGR)$1.4B
Azenta (AZTA)$1.4B
Clover Health Investments (CLOV)$1.3B
Claritev (CTEV)$1.1B
Evolent Health (EVH)$1.1B
Fulgent Genetics (FLGT)$679M
Zepp Health (ZEPP)$652M
Veradigm (MDRX)$531M
Standard BioTools (LAB)$481M
Talkspace (TALK)$445M
Butterfly Network (BFLY)$405M
Carlsmed (CARL)$354M
TruBridge (TBRG)$300M
Outset Medical (OM)$247M
Health Catalyst (HCAT)$239M
SOPHiA GENETICS SA (SOPH)$234M
Nyxoah SA (NYXH)$213M
KORU Medical Systems (KRMD)$195M